Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats
Montserrat Victoriano, Dominique Hermier, Patrick C. Even, et al.
Psychopharmacology (2009) Vol. 206, Iss. 1, pp. 167-176
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters
Kieran Davey, Siobhain M. O’Mahony, Harriët Schellekens, et al.
Psychopharmacology (2012) Vol. 221, Iss. 1, pp. 155-169
Closed Access | Times Cited: 258
Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat
Kieran Davey, Paul D. Cotter, Órla O’Sullivan, et al.
Translational Psychiatry (2013) Vol. 3, Iss. 10, pp. e309-e309
Open Access | Times Cited: 220
Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design
Roberto Coccurello, Anna Moles
Pharmacology & Therapeutics (2010) Vol. 127, Iss. 3, pp. 210-251
Closed Access | Times Cited: 146
Preclinical models of antipsychotic drug-induced metabolic side effects
Heidi N. Boyda, Lurdes Tse, Ric M. Procyshyn, et al.
Trends in Pharmacological Sciences (2010) Vol. 31, Iss. 10, pp. 484-497
Closed Access | Times Cited: 103
<p>Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review</p>
Haiyun Xu, Xiaoyin Zhuang
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2087-2099
Open Access | Times Cited: 61
Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics
Antonella Campanale, Antonio Inserra, Stefano Comai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 134, pp. 111058-111058
Open Access | Times Cited: 5
Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients
Anindya Dasgupta, Om Prakash Singh, Jayanta Kumar Rout, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2010) Vol. 34, Iss. 7, pp. 1202-1207
Closed Access | Times Cited: 57
Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats
Heidi N. Boyda, Alfredo Ramos‐Miguel, Ric M. Procyshyn, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 77-90
Open Access | Times Cited: 48
Preclinical and Clinical Sex Differences in Antipsychotic-Induced Metabolic Disturbances: A Narrative Review of Adiposity and Glucose Metabolism
L Castellani, Kenya A. Costa-Dookhan, William Brett McIntyre, et al.
Journal of Psychiatry and Brain Science (2019)
Open Access | Times Cited: 40
Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state
Montserrat Victoriano, Renaud de Beaurepaire, Nadia Naour, et al.
Brain Research (2010) Vol. 1350, pp. 167-175
Closed Access | Times Cited: 51
Modelling olanzapine-induced weight gain in rats
Esther M. van der Zwaal, Sanna K. Janhunen, Susanne E. la Fleur, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 169-186
Closed Access | Times Cited: 40
Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Catherine C.Y. Pang, et al.
PLoS ONE (2013) Vol. 8, Iss. 1, pp. e53459-e53459
Open Access | Times Cited: 39
Atypical antipsychotics and effects on feeding: from mice to men
Louise Benarroch, Chantel Kowalchuk, Virginia Wilson, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2629-2653
Closed Access | Times Cited: 35
Olanzapine affects locomotor activity and meal size in male rats
Esther M. van der Zwaal, Mieneke C. M. Luijendijk, Simon S. Evers, et al.
Pharmacology Biochemistry and Behavior (2010) Vol. 97, Iss. 1, pp. 130-137
Closed Access | Times Cited: 40
Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics
Ana Maria Volpato, Alexandra I. Zugno, João Quevedo
Brazilian Journal of Psychiatry (2013) Vol. 35, Iss. 3, pp. 295-304
Open Access | Times Cited: 28
Binge Eating Disorders in Antipsychotic-Treated Patients With Schizophrenia
Renaud de Beaurepaire
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 2, pp. 114-120
Closed Access | Times Cited: 19
Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats
Simon S. Evers, Federica Calcagnoli, Gertjan van Dijk, et al.
Pharmacology Biochemistry and Behavior (2010) Vol. 97, Iss. 1, pp. 163-169
Open Access | Times Cited: 30
Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance
Benjamin Guesdon, R Denis, Denis Richard
Behavioural Brain Research (2009) Vol. 207, Iss. 1, pp. 14-20
Closed Access | Times Cited: 26
An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
Claire Wu, Jessica W. Y. Yuen, Heidi N. Boyda, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107116-e107116
Open Access | Times Cited: 20
Exercise prevents downregulation of hippocampal presynaptic proteins following olanzapine-elicited metabolic dysregulation in rats: Distinct roles of inhibitory and excitatory terminals
Alfredo Ramos‐Miguel, William G. Honer, Heidi N. Boyda, et al.
Neuroscience (2015) Vol. 301, pp. 298-311
Closed Access | Times Cited: 16
Long term ingestion of a preload containing fructo-oligosaccharide or guar gum decreases fat mass but not food intake in mice
Zouheyr Hadri, Catherine Chaumontet, Gilles Fromentin, et al.
Physiology & Behavior (2015) Vol. 147, pp. 198-204
Closed Access | Times Cited: 11
Dietary Fibers Solubilized in Water or an Oil Emulsion Induce Satiation through CCK-Mediated Vagal Signaling in Mice3
Rojo Rasoamanana, Catherine Chaumontet, Nachiket A. Nadkarni, et al.
Journal of Nutrition (2012) Vol. 142, Iss. 11, pp. 2033-2039
Open Access | Times Cited: 10
Subchronic olanzapine treatment decreases the expression of pancreatic glucose transporter 2 in rat pancreatic β cells
Shengqiang Shu, Hao Liu, Min Wang, et al.
Journal of Endocrinological Investigation (2014) Vol. 37, Iss. 7, pp. 667-673
Closed Access | Times Cited: 5
A Possible Role of Akkermansia muciniphila in the Treatment of Olanzapine-Induced Weight Gain
F. Bertossi
Cureus (2024)
Open Access
Early ethanol and water consumption: Accumulating experience differentially regulates drinking pattern and bout parameters in male alcohol preferring (P) vs. Wistar and Sprague Dawley rats
A. V. Аzarov, Donald J. Woodward
Physiology & Behavior (2013) Vol. 123, pp. 20-32
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top